Skip to main content

Deep Learning-Derived Retinal Vascular Morphology and Incident Treatment for Sight-Threatening Diabetic Retinopathy

In brief

Deep-learning retinal vessel measures tracked treatment risk in 1 in 10 eyes

Among 33,861 eyes followed for an average of 1.7 years, 10.2% received treatment for sight-threatening diabetic retinopathy. Greater arterial complexity and density were associated with lower treatment risk, while wider veins were associated with higher risk; these observational findings suggest retinal vessel measures could aid risk prediction, but their value in clinical models remains to be tested.

Journal
Ophthalmology science (Q1)
Published
26 August 2026
Study design
Retrospective cohort
Evidence level
Level 3, Low (CEBM 3b)
Authors
Paul Nderitu, Mark Chia, Urvi Karamchandani, Christine A Kiire, Asterios Diafas, Sarah Matta, et al.
PMID
42857094
DOI
10.1016/j.xops.2026.101385

Why clinicians should know about it

  • Picked for Ophthalmology (paper of the day, 14 October 2026): Deep‑learning retinal features predict STDR treatment risk

Abstract

OBJECTIVE: Retinal vascular morphology (RVM) features could be useful biomarkers for risk stratification for incident sight-threatening diabetic retinopathy (STDR). We evaluated whether deep learning-derived macula-centered RVM, extracted at scale, are associated with incident treatment for STDR including proliferative diabetic retinopathy (PDR) and clinically significant macula edema (CSME). DESIGN: Retrospective longitudinal cohort study (2000-2022). PARTICIPANTS: We included 20 855 patients (33 861 eyes) with gradable, treatment-naïve eyes with a macula-centered fundus image at baseline. METHODS: Arterial and venous RVM features of complexity, density, caliber, and tortuosity were extracted using an automated deep learning tool (AutoMorph). Multivariable Cox proportional hazards models were performed to quantify the association between RVM and incident treatment for STDR, adjusting for age, sex, ethnicity, baseline diabetic retinopathy (DR) and diabetic macula edema (DME) grade, and intereye correlation using a cluster term. MAIN OUTCOME MEASURES: Incident treatment for STDR including PDR or CSME. RESULTS: Over a mean 1.74 (standard deviation 2.15) years of follow-up, 3446 eyes (10.2%) received treatment for STDR (1387 PDR; 2059 CSME). Higher arterial complexity and density were strongly protective for incident STDR treatment (arterial complexity Q4 vs. Q1 hazard ratio [HR] 0.52 [95% confidence interval 0.45-0.60]; arterial density HR 0.47 [0.41-0.54]). Larger venous caliber was associated with an increased risk of incident STDR treatment (HR 2.53 [2.23-2.86]), while increasing arterial caliber was associated with a reduced risk of incident PDR treatment (HR 0.64 [0.53-0.77]). There were weak associations between increasing arterial and venous tortuosity and an increased risk of incident treatment for PDR and CSME, respectively (arterial tortuosity HR 1.11 [95% confidence interval 1.01-1.22]; venous tortuosity HR 1.16 [1.03-1.31]). Retinal vascular morphology feature associations were generally stronger for incident treatment for PDR than CSME. Associations between RVM and incident treatment for STDR remained consistent after a sensitivity analysis which only included patients with no or mild DR and no DME at baseline. CONCLUSIONS: Macula-centered RVM features show clinically plausible associations with incident treatment for STDR. Retinal vascular morphology features extracted using an automated deep learning tool are potential prognostic biomarkers that could be useful for DR risk prediction models alongside other retinal imaging biomarkers and clinical risk factors. FINANCIAL DISCLOSURES: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.